KDx Diagnostics gets FDA breakthrough device status for URO17 bladder cancer recurrence test
The FDA has granted breakthrough device status for URO17 bladder cancer recurrence test (Credit: Pixabay/Ewa Urban)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X